The overall objective of GBA is to:
1. Develop, promote, and support non-commercial biofoundries established around the world, 2. Intensify collaboration and communication among biofoundries, 3. Collectively develop responses to technological, operational, and other types of common challenges, 4. Enhance visibility, impact and sustainability of non-commercial biofoundries, and 5. Explore globally relevant and societally impactful grand challenge collaborative projects.
Information
Stories
A high-throughput pipeline for scalable kit-free RNA extraction6 December, 2021Posted in:Publication-Ping Han, Maybelle K. Go, Jeng Yeong Chow, Bo Xue, Yan Ping Lim, Michael A. Crone, Marko Storch, Paul S. Freemont & Wen Shan Yew Given the global over-reliance on commercial, kit-based RNA extraction in the molecular diagnoses of infectious diseases such as SARS-CoV-2, past challenges in the event of supply chain disruptions have hindered testing capacity in times of need. Apart from supply
Building Biofoundry India: challenges and path forward21 July, 2021Posted in:Publication-Binay Panda, Pawan K Dhar Abstract Biofoundry is a place where biomanufacturing meets automation. The highly modular structure of a biofoundry helps accelerate the design-build–test–learn workflow to deliver products fast and in a streamlined fashion. In this perspective, we describe our efforts to build Biofoundry India, where we see the facility add a substantial value in
DNA Scanner: a web application for comparing DNA synthesis feasibility, price and turnaround time across vendors18 October, 2021Posted in:Publication-DNA synthesis has become a major enabler of modern bioengineering, allowing scientists to simply order online in silico-designed DNA molecules. Rapidly decreasing DNA synthesis service prices and the concomitant increase of research and development scales bolstered by computer-aided DNA design tools and laboratory automation has driven up the demand for synthetic DNA.
Building a biofoundry18 October, 2021Posted in:Publication-A biofoundry provides automation and analytics infrastructure to support the engineering of biological systems. It allows scientists to perform synthetic biology and aligned experimentation on a high-throughput scale, massively increasing the solution space that can be examined for any given problem or question.
GBA Webinar with Dr Rosalind Le Feuvre & Dr Mark Dörr14 April, 2021Posted in:Events-2021 Global Biofoundries Alliance Webinar Series April 20th 2021 @ 1-2 pm CET Register in advance for this webinar: https://lbnl.zoom.us/webinar/register/WN_x6S_QgwHTFeSnBCSmsfxMg A recording of the webinar will be made publicly available after the event for those unable to attend. This is a public webinar, so please do share this announcement with others that may be interested
London Biofoundry testing and pooling projects19 March, 2021Posted in:Research-In early 2020, due to reagent and labware shortages, there were significant limitations on SARS-CoV-2 testing capacity worldwide, with the UK’s diagnostic capacity at only 10 000 tests per day at the beginning of April. The London Biofoundry worked together with NHS colleagues to successfully increase testing capacity in accredited NHS laboratories at the St
Building a global alliance of biofoundries18 November, 2019Posted in:News-Nathan Hillson, Mark Caddick, […]Paul S. Freemont Nature Communications volume 10, Article number: 2040 (2019) Biofoundries provide an integrated infrastructure to enable the rapid design, construction, and testing of genetically reprogrammed organisms for biotechnology applications and research. Many biofoundries are being built and a Global Biofoundry Alliance has recently been established to coordinate activities worldwide.
Global Biofoundry Meeting, London, June 201825 June, 2019Posted in:News-A meeting was held at Imperial College London on June 21st/22nd 2018, which gathered fifteen[1]of the leading synthetic biology biofoundries from around the world to discuss current activities and exchange information on key capabilities and projects being developed by these groups. Originally posted by SynbiCITE on 25 June, 2018 The meeting explored opportunities for collaboration and
We're #hiring a computational biologist project scientist.
In this role, you will use artificial intelligence to design living cells for the production of renewable energy and bioproducts, and combat climate change.
Safety first! We want to take care of both #VTTpeople and stakeholders. The #ISO45001 certificate granted to us in Dec 2021 serves as proof that we have successfully reached this goal ➡️ https://t.co/ISyJztncnx
From 2014, we have partnered with @RockleyPhotonic to develop photonic integrated circuits. These small wonders minimise the cost, power consumption and size of health & well-being #wearables and are now available for the consumer & MedTech markets!⌚https://t.co/FmXkgKzLep
Mistä Suomen seuraavat startup-menestyjät nousevat? @ahavasara listasi 3 syväteknologia-alaa, jotka voivat mullistaa globaalia taloutta ja luoda uutta, kestävää teollisuutta Suomeen 🌱
Food security is an ongoing challenge in sub-Saharan Africa. Raised in a drought-prone area of Kenya, entomology professor @EstherNgumbi says insects can be a sustainable source of food and nutrition.
Novo Nordisk Foundation project grants within the natural and technical sciences will enable 21 basic science research projects to be realised over the coming years. Each project has been awarded a grant of up to DKK 3 million.
https://t.co/DyOia0HNEX
Together with @novoholdings, the NNF has embarked on a journey to make #biotechnology a spearhead for the #greentransition of society. We are committed to doing our part – all the way from ground-breaking ideas to delivery of solutions.
A high-throughput pipeline for scalable kit-free RNA extraction 6 December, 2021 Posted in: Publication - Ping Han, Maybelle K. Go, Jeng Yeong Chow, Bo Xue, Yan Ping Lim, Michael A. Crone, Marko Storch, Paul S. Freemont & Wen Shan Yew Given the global over-reliance on commercial, kit-based RNA extraction in the molecular diagnoses of infectious diseases such as SARS-CoV-2, past challenges in the event of supply chain disruptions have hindered testing capacity in times of need. Apart from supply
DNA Scanner: a web application for comparing DNA synthesis feasibility, price and turnaround time across vendors 18 October, 2021 Posted in: Publication - DNA synthesis has become a major enabler of modern bioengineering, allowing scientists to simply order online in silico-designed DNA molecules. Rapidly decreasing DNA synthesis service prices and the concomitant increase of research and development scales bolstered by computer-aided DNA design tools and laboratory automation has driven up the demand for synthetic DNA.
Building a biofoundry 18 October, 2021 Posted in: Publication - A biofoundry provides automation and analytics infrastructure to support the engineering of biological systems. It allows scientists to perform synthetic biology and aligned experimentation on a high-throughput scale, massively increasing the solution space that can be examined for any given problem or question. 
A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics 19 May, 2021 Posted in: Publication - Michael A. Crone, Miles Priestman, Marta Ciechonska, Kirsten Jensen, David J. Sharp, Arthi Anand, Paul Randell, Marko Storch & Paul S. Freemont A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics | Nature Communications
London Biofoundry testing and pooling projects 19 March, 2021 Posted in: Research - In early 2020, due to reagent and labware shortages, there were significant limitations on SARS-CoV-2 testing capacity worldwide, with the UK’s diagnostic capacity at only 10 000 tests per day at the beginning of April. The London Biofoundry worked together with NHS colleagues to successfully increase testing capacity in accredited NHS laboratories at the St
Building a global alliance of biofoundries 18 November, 2019 Posted in: News - Nathan Hillson, Mark Caddick, […]Paul S. Freemont Nature Communications volume 10, Article number: 2040 (2019) Biofoundries provide an integrated infrastructure to enable the rapid design, construction, and testing of genetically reprogrammed organisms for biotechnology applications and research. Many biofoundries are being built and a Global Biofoundry Alliance has recently been established to coordinate activities worldwide.
Global Biofoundry Meeting, London, June 2018 25 June, 2019 Posted in: News - A meeting was held at Imperial College London on June 21st/22nd 2018, which gathered fifteen[1]of the leading synthetic biology biofoundries from around the world to discuss current activities and exchange information on key capabilities and projects being developed by these groups. Originally posted by SynbiCITE on 25 June, 2018 The meeting explored opportunities for collaboration and
